Target intelligence / Profile preview

Ribosomal protein L3 pseudogene 7 (RPL3P7)

Target
RPL3P7
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L3 pseudogene 7 (RPL3P7) is a processed pseudogene derived from the ribosomal protein L3 gene (RPL3). Unlike the functional RPL3 gene, which encodes an essential structural protein for the 60S ribosomal subunit, RPL3P7 does not produce a functional protein product and is not involved in protein synthesis or canonical ribosomal activities. The presence of RPL3P7 reflects the common phenomenon of ribosomal protein genes being duplicated and retrotransposed throughout the genome as pseudogenes. Such pseudogenes are generally considered nonfunctional genomic elements, although they may occasionally be coexpressed in gene expression datasets. RPL3P7 is referenced in some high-throughput studies as part of gene expression clusters correlating with cancer incidence, but this is likely as a bystander effect rather than a functional causal role. There are no known drugs acting on this pseudogene, nor is it classified as an actionable therapeutic target for any disease.

Other names
RPL3_3_732RPL3P7[7][2]
02

Mechanism of action

None known; as a pseudogene, RPL3P7 does not encode a protein product and is not a target of drugs or small molecules

03

Biological functions

None assigned; pseudogenes are generally considered non-functional in protein-coding capacity
04

Disease associations

Some evidence of correlation with cancer incidence in large-scale gene-expression studies, likely as a passenger marker and not a causative geneNo direct functional disease mechanism known
05

Safety considerations

None known
06

Interacting drugs

None
07

Biomarkers

None establishedMentioned only incidentally as a co-expressed element in certain gene expression signatures correlated with cancer incidence

Beyond the preview

Go deeper on Ribosomal protein L3 pseudogene 7 (RPL3P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L3 pseudogene 7 (RPL3P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call